Use of Vitamin D Supplement as an Adjunct Therapy for Treating Stroke

Use of Vitamin D Supplement as an Adjunct Therapy for Treating Stroke
Student Name
Institutional Affiliation
Use of Vitamin D Supplement as an Adjunct Therapy for Treating Stroke
Having a low vitamin D status is a common forms of health problems owing to the fact that it affects almost one in every two people and it has adverse effects on one’s health. Existing findings from previous studies shows that vitamin D deficiency exposes an individual to musculoskeletal, cardiovascular, infectious, malignant diseases, renal diseases, and autoimmune diseases (Garg et al. 2013; Langlois et al. 2010; Bodnar et al. 2013). The findings also show that a poor vitamin D also leads to increased risks of stroke and poor health outcomes among post-stroke patients. This is important because stroke has been established as the third highest cause of death and among the leading in causing disability among patients (Dickens et al. 2011). Owing to its high incidence, it is important to establish approaches of preventing and treating stroke so as to help in reduction of the related mortality, morbidity, and healthcare costs.
PICOT Question
P
PopulationI
InterventionC
ComparatorO
OutcomeSearchPatients with stroke. Vitamin D supplementation. Different effects of vitamin D supplementation.
Effects of vitamin D deficiency. Treatment of stroke.
Reduction of risk factors to stroke.What is the impact of using vitamin D supplement as a adjunct therapy for treating stroke on healthcare outcomes among stroke patients?
Literature
Sufficient epidemiological evidence demonstrates that the lack of adequate vitamin D is closely linked with high risk of strokes. Remarkably, several researchers have focused on establishing regional and seasonal stroke incidence differences (Matsuda and Shimomura 2013). Although their submissions were inconsistent, most studies showed that the incidences of stroke are likely to rise during wintertime and at low elevations. This is because of the general presence of low UV-B radiation at lower altitudes and in winter and consequently lowers levels of 25(OH)D. There are several probable explanations for the concluding findings but the opinions postulated in this research are suitable in the hypothesis that 25(OH)D levels present risks for cerebrovascular occurrences (Donley et al. 2014). Similarly, studies found that after 30 days of the initial stroke incidence ever, patients showed notably inferior level 25(OH)D in comparison to healthy elder subjects. This research is supported by other works that found out that people bearing records of stroke and cases with MRI cerebrovascular infection signs had minimized levels of 25(OH)D.
Some hopeful researchers such as Koizumi et al. (2011) have now explicitly offered solutions to the inquiry if the levels of 25(OH)D are predictors of future stroke risks. A previous research by Ketteler et al. (2012) examined 755 elderly subjects and followed their history for ten years in which 70 strokes were witnessed during the observation duration, but the levels of 25(OH)D were not significant between examinations (11.9±7.2 ng/ml) and control experiments (12.5±7.8 ng/ml). Nevertheless, in comparison to the least tertile in the levels of...